Is AVTE or JEPQ a better dividend investment in 2026?

AVTE currently yields 74.63% with a 5% 5-year dividend growth rate. JEPQ yields 11.47% with 5% growth. The better choice depends on your goal: AVTE offers higher current income.

What is the dividend yield difference between AVTE and JEPQ?

AVTE has a forward dividend yield of 74.63% ($2.00/share annually). JEPQ yields 11.47% ($6.16/share annually). The yield gap is 63.16 percentage points.

Home › Compare › AVTE vs JEPQ

AVTE vs JEPQ: Dividend Comparison 2026

AVTE yields 74.63% · JEPQ yields 11.47%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVTE wins by $1.26M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVTE

● Live price

74.63%

Share price

$2.68

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.30M

Annual income

$358,033.82

Full AVTE calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.47%

Share price

$53.77

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.8K

Annual income

$2,269.18

Full JEPQ calculator →

Portfolio growth — AVTE vs JEPQ

📍 AVTE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVTE	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVTE + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVTE pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVTE

Annual income on $10K today (after 15% tax)

$6,343.28/yr

After 10yr DRIP, annual income (after tax)

$304,328.75/yr

JEPQ

Annual income on $10K today (after 15% tax)

$974.55/yr

After 10yr DRIP, annual income (after tax)

$1,928.80/yr

At 15% tax rate, AVTE beats the other by $302,399.94/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVTE + JEPQ for your $10,000?

AVTE: 50%JEPQ: 50%

100% JEPQ50/50100% AVTE

Portfolio after 10yr

$673.8K

Annual income

$180,151.50/yr

Blended yield

26.74%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on AVTE right now

AVTE

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$13.00

+385.1% upside vs current

Range: $2.00 — $35.00

Altman Z

2.1

Piotroski

2/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVTE buys

JEPQ buys

No recent congressional trades found for AVTE or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVTEJEPQ

Forward yield	74.63% ✓	11.47%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.30M	$45.8K ✓
Annual income after 10y	$358,033.82 ✓	$2,269.18
Total dividends collected	$1.12M	$17.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: AVTE vs JEPQ ($10,000, DRIP)

Year	AVTE Portfolio	AVTE Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$18,163	$7,462.69	$11,967	$1,146.53	+$6.2K → AVTE
2	$32,102	$12,667.52	$14,216	$1,268.02	+$17.9K → AVTE
3	$55,273	$20,924.46	$16,774	$1,392.20	+$38.5K → AVTE
4	$92,813	$33,671.17	$19,667	$1,518.21	+$73.1K → AVTE
5	$152,151	$52,841.00	$22,925	$1,645.21	+$129.2K → AVTE
6	$243,759	$80,956.60	$26,578	$1,772.40	+$217.2K → AVTE
7	$382,036	$121,213.91	$30,656	$1,899.04	+$351.4K → AVTE
8	$586,325	$177,546.69	$35,194	$2,024.45	+$551.1K → AVTE
9	$882,029	$254,661.46	$40,228	$2,148.01	+$841.8K → AVTE
10	$1,301,805	$358,033.82	$45,796	$2,269.18	+$1.26M → AVTE

AVTE vs JEPQ: Complete Analysis 2026

AVTE — Stock

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Full AVTE Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this AVTE vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVTE vs SCHD AVTE vs JEPI AVTE vs O AVTE vs KO AVTE vs MAIN AVTE vs XYLD AVTE vs QYLD AVTE vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.